These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3968496)

  • 1. Rapid changes in growth hormone regulation and hypothalamic somatostatin after transection of anterolateral pathways to the medial-basal hypothalamus in the rat.
    Kakucska I; Antal M; Kárteszi M; Makara GB
    J Endocrinol; 1985 Jan; 104(1):121-7. PubMed ID: 3968496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone releasing activity persists in the deafferented medial-basal hypothalamus of the rat.
    Antoni FA; Makara GB; Rappay G
    J Endocrinol; 1981 Dec; 91(3):415-25. PubMed ID: 6120201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible role of hypothalamic somatostatin in the maintenance of rat pituitary responsiveness to growth hormone-releasing factor.
    Soya H; Suzuki M
    Endocrinology; 1990 Jan; 126(1):285-91. PubMed ID: 1967163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caloric intake stimulates growth hormone secretion in food-deprived rats with anterolateral deafferentation of the medial basal hypothalamus or administered antiserum to somatostatin.
    Suzuki N; Okada K; Sugihara H; Minami S; Wakabayashi I
    J Neuroendocrinol; 1995 Jun; 7(6):483-90. PubMed ID: 7550296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone synthesis decreased after anterolateral deafferentation of the medial basal hypothalamus in the rat.
    Ieiri T; Ishikawa K; Suzuki M; Shimoda S
    Neuroendocrinology; 1988 May; 47(5):431-6. PubMed ID: 3399030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effect of hypothalamic medial preoptic area somatostatin on growth hormone-releasing factor in the rat.
    Katakami H; Downs TR; Frohman LA
    Endocrinology; 1988 Aug; 123(2):1103-9. PubMed ID: 2899498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone releasing effect of hpGRF-40 in rats at different time intervals following ablation of the mediobasal hypothalamus.
    Locatelli V; Cella SG; Loche S; Pintor C; Müller EE
    Life Sci; 1984 Nov; 35(19):1989-95. PubMed ID: 6436609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogenetic development of the inhibition of growth hormone release by somatostatin in the rat: in-vivo and in-vitro (perifusion) study.
    Rieutort M
    J Endocrinol; 1981 Jun; 89(3):355-63. PubMed ID: 6114124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin content of the median eminence in female rats with lesion-induced disruption of the inhibitory control of growth hormone secretion.
    Critchlow V; Rice RW; Abe K; Vale W
    Endocrinology; 1978 Sep; 103(3):817-25. PubMed ID: 744118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Various putative neurotransmitters affect growth hormone (GH) release in rats with anterolateral hypothalamic deafferentation of the medial basal hypothalamus: evidence for mediation by a GH-releasing factor.
    Kakucska I; Makara GB
    Endocrinology; 1983 Jul; 113(1):318-23. PubMed ID: 6190642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of gamma-aminobutyric acid (GABA)-mediated inhibition of growth hormone secretion in the rat.
    Fiók J; Acs Z; Makara GB; Erdö SL
    Neuroendocrinology; 1984 Dec; 39(6):510-6. PubMed ID: 6151130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin-like immunoreactivity in duck plasma, hypothalamus and neural lobe during post-hatch growth: comparison with plasma and pituitary growth hormone concentrations.
    Foltzer C; Harvey S; Mialhe P
    J Endocrinol; 1987 Apr; 113(1):57-63. PubMed ID: 2884270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired growth hormone secretion in neonatal hypothyroid rats: hypothalamic versus pituitary component.
    De Gennaro V; Cella SG; Bassetti M; Rizzi R; Cocchi D; Muller EE
    Proc Soc Exp Biol Med; 1988 Jan; 187(1):99-106. PubMed ID: 3124121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
    Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
    Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin.
    Locatelli V; Torsello A; Redaelli M; Ghigo E; Massare F; Müller EE
    J Endocrinol; 1986 Nov; 111(2):271-8. PubMed ID: 2878963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual and developmental differences in peptides regulating growth hormone secretion in the rat.
    Gabriel SM; Millard WJ; Koenig JI; Badger TM; Russell WE; Maiter DM; Martin JB
    Neuroendocrinology; 1989 Sep; 50(3):299-307. PubMed ID: 2571953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary concentration of GH messenger ribonucleic acid in rats with anterolateral hypothalamic deafferentation.
    Kato Y; Ishikawa K; Ieiri T; Imai K; Suzuki M
    Endocrinol Jpn; 1989 Feb; 36(1):87-93. PubMed ID: 2731486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
    Doi N; Hirotani C; Ukai K; Shimada O; Okuno T; Kurasaki S; Kiyofuji T; Ikegami R; Futamata M; Nakagawa T; Ase K; Chihara K
    Arzneimittelforschung; 2004; 54(12):857-67. PubMed ID: 15646370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.